Mosaicism of a Truncating Variant of CASK Causes Congenital Heart Disease and Neurodevelopmental Disorder

Mol Syndromol. 2023 Jan;13(6):517-521. doi: 10.1159/000524375. Epub 2022 May 5.

Abstract

Introduction: Calcium/calmodulin-dependent serine protein kinase (CASK) gene mutations cause microcephaly with pontine and cerebellar hypoplasia (MICPCH) and X-linked intellectual disability. Congenital heart disease (CHD) is a rare complication reported in only 4 male patients with full loss-of-function mutations. Here, we report the first male patient with mosaicism of a truncating variant of CASK complicated by CHD.

Case presentation: The patient is a 6-year-old male with MICPCH, ventricular septal defect, and developmental delay. He achieved rolling over but can not speak meaningful words. We identified a somatic mosaic variant of CASK: c.[725=/G>A], p.(W242*) and high mosaic ratios of 90% and 84% for mutant alleles in peripheral blood lymphocytes and skin fibroblasts, respectively. His developmental delay was severe but milder than that of previously reported CHD patients.

Discussion: Truncating CASK variants may be associated with CHD, even in a mosaic state, and even a low normal allele ratio could lengthen survivorship.

Keywords: CASK; Congenital heart disease; Mosaicism; Neurodevelopmental disorders; Truncating variant.

Publication types

  • Case Reports

Grants and funding

This research was supported in part by a Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan, the Initiative on Rare and Undiagnosed Diseases (19ek0109301h0002) from the Japan Agency for Medical Research and Development, and JSPS KAKENHI 20K08270 (K.K.).